Colorado Coagulation Competitors and Similar CompaniesClear all
Colorado Coagulation's competitors and similar companies include CoaguSense, Arch Therapeutics, Entegrion and Molinos.
 Colorado Coagulation Colorado Coagulation Consultants is a company that specializes in hemostasis testing. |  Arch Therapeutics Arch Therapeutics is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. |  Entegrion Entegrion is a life sciences company providing solutions for clinical diagnosis and management of hemostasis. | |||
Founding Date | Founding Date 1998 | Founding Date 2008 | Founding Date 2006 | Founding Date 2002 | Founding Date 1902 |
Type | Type Subsidiary | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Englewood, US HQ | Locations Fremont, US HQ | Locations Framingham, US HQ | Locations Durham, US HQ | Locations Victoria, AR HQ Rosario, AR |
Employees | Employees 5 | Employees 257% decrease | Employees 8 | Employees 128% decrease | Employees 6,234 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $75.7k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $951.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $78.2k (FY, 2023) | Cost of goods N/A | Cost of goods $700.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ($2.4k) (FY, 2023) | Gross profit N/A | Gross profit $256.4b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($7m) (FY, 2023) | Net income N/A | Net income ($40.7b) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3m (almost 11 years ago) | Latest funding round $ 257.2k (over 16 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 5.9m | Total funding raised $ 257.2k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CoaguSense
HQ
Fremont, US
Employees
25↓ 7% decrease
CoaguSense is a manufacturer of coagulation in-vitro diagnostic devices.
View companyArch Therapeutics
HQ
Framingham, US
Employees
8
Arch Therapeutics is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care.
View companyEntegrion
HQ
Durham, US
Employees
12↓ 8% decrease
Entegrion is a life sciences company providing solutions for clinical diagnosis and management of hemostasis.
View company